Amarantus Bioscience Holdings Inc. (AMBS)

Last Closing Price: --

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Amarantus Bioscience Holdings Inc. (AMBS) had Net Income of $-37.06M for the most recently reported fiscal year, ending 2015-12-31.

Figures for fiscal year ending 2015-12-31
Income Statement Financials
--
Net Income
$-37.06M
--
--
$24.82M
$-24.82M
$-0.39M
$-25.21M
$-25.21M
$-25.21M
$-25.21M
$-25.21M
$-25.21M
$-24.82M
$-23.16M
8.88M
8.88M
$-4.17
$-4.17
Balance Sheet Financials
$0.83M
$0.12M
$10.94M
$11.77M
$16.19M
--
$1.11M
$17.30M
$-17.45M
$-16.36M
$-5.53M
21.18M
Cash Flow Statement Financials
$-16.01M
$-4.91M
$20.89M
$0.21M
$0.18M
$-0.04M
$2.16M
--
--
Fundamental Metrics & Ratios
0.05
--
--
--
-0.53
--
--
--
--
--
--
$-16.02M
--
--
--
--
--
--
--
144.47%
154.10%
-214.20%
455.62%
$-0.26
$-1.80
$-1.80